Literature DB >> 21311116

Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.

Denis Viglietti1, Jérôme Verine, Nathalie De Castro, Anne Scemla, Michel Daudon, Denis Glotz, Evangeline Pillebout.   

Abstract

Here, we report a case of chronic granulomatous tubulo-interstitial nephritis related to atazanavir crystals in a HIV type-1-infected patient. Renal function in this patient was partially recovered after atazanavir withdrawal and steroid therapy. Many reports have described atazanavir-associated urolithiasis, but this is the first case that describes chronic granulomatous nephropathy.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21311116     DOI： 10.3851/IMP1700

Source DB:  PubMed          Journal:  Antivir Ther        ISSN： 1359-6535


  13 in total

Review 1.  Clinical Pharmacology in HIV Therapy.

Authors:  Mohamed G Atta; Sophie De Seigneux; Gregory M Lucas
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-29       Impact factor: 8.237

Review 2.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

Review 3.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

4.  Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors.

Authors:  Geoffroy Liegeon; Linda Harrison; Anouar Nechba; Guttiga Halue; Sukit Banchongkit; Ampaipith Nilmanat; Naruepon Yutthakasemsunt; Panita Pathipvanich; Suchart Thongpaen; Rittha Lertkoonalak; Thomas Althaus; Marc Lallemant; Jean-Yves Mary; Gonzague Jourdain
Journal:  J Infect       Date:  2019-08-08       Impact factor: 6.072

Review 5.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 6.  Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients.

Authors:  Minoru Ando; Naoki Yanagisawa
Journal:  World J Nephrol       Date:  2015-07-06

Review 7.  Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challenge.

Authors:  Neelja Kumar; Mark A Perazella
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.495

8.  Atazanavir nephrotoxicity.

Authors:  Masaki Hara; Akihiko Suganuma; Naoki Yanagisawa; Akifumi Imamura; Tsunekazu Hishima; Minoru Ando
Journal:  Clin Kidney J       Date:  2015-03-20

Review 9.  HIV medication-based urolithiasis.

Authors:  Hassane Izzedine; François Xavier Lescure; Fabrice Bonnet
Journal:  Clin Kidney J       Date:  2014-03-11

10.  Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function.

Authors:  Maria Concetta Postorino; Eugenia Quiros-Roldan; Franco Maggiolo; Simona Di Giambenedetto; Nicoletta Ladisa; Giuseppe Lapadula; Silvia Lorenzotti; Laura Sighinolfi; Filippo Castelnuovo; Massimo Di Pietro; Daria Gotti; Nicola Mazzini; Carlo Torti
Journal:  Open AIDS J       Date:  2016-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.